Key Insight: GLP-1 Side Effects Are Microbiome-Driven Most people assume that GLP-1 side effects are purely mechanical: the drug slows digestion, so they feel bloated
GLP-1 medications have long half-lives and bind strongly to proteins in your blood, which means even small amounts can sustain receptor activation over time
Shorter courses produce less total weight loss and may not allow enough time for metabolic adaptation
Who Each Medication Might Suit Patient Profiles Tirzepatide Good Fit If You Want: A well-studied, clinically proven option Steady, predictable fat loss and metabolic support An accessible medication now (current approval and availability) Balanced results with moderate side-effect profile Retatrutide May Be Ideal If You Want: A next-generation therapy with stronger fat-loss potential Deeper metabolic shift and body-composition changes A more aggressive approach and are open to an investigational therapy with close supervision The possibility of enhanced energy expenditure and fat oxidation beyond appetite suppression At Everest, we believe the right choice depends on your goals, health history, metabolic profile, and readiness for advanced care not on hype or trends
GLP-1-stimulering via lkemedel har ven visat skydd av hjrta, njurar och lever
The TRIUMPH trials are currently ongoing, and their data will form the evidence base required for regulatory review by the MHRA and EMA